Editorial: Targeting metabolism in cancer immunotherapy

Jason Roszik, Keiji Tanese, Suhendan Ekmekcioglu

Research output: Contribution to journalEditorial

2 Citations (Scopus)
Original languageEnglish
Article number2029
JournalFrontiers in Immunology
Volume9
Issue numberSEP
DOIs
Publication statusPublished - 2018 Sep 11

Fingerprint

Immunotherapy
Neoplasms

Keywords

  • Cancer
  • Immune cells
  • Immunotherapy
  • Metabolism
  • Tumor microenvironment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Editorial : Targeting metabolism in cancer immunotherapy. / Roszik, Jason; Tanese, Keiji; Ekmekcioglu, Suhendan.

In: Frontiers in Immunology, Vol. 9, No. SEP, 2029, 11.09.2018.

Research output: Contribution to journalEditorial

Roszik, Jason ; Tanese, Keiji ; Ekmekcioglu, Suhendan. / Editorial : Targeting metabolism in cancer immunotherapy. In: Frontiers in Immunology. 2018 ; Vol. 9, No. SEP.
@article{903ef2c04bf5424e8d7c5b21f3fc774e,
title = "Editorial: Targeting metabolism in cancer immunotherapy",
keywords = "Cancer, Immune cells, Immunotherapy, Metabolism, Tumor microenvironment",
author = "Jason Roszik and Keiji Tanese and Suhendan Ekmekcioglu",
year = "2018",
month = "9",
day = "11",
doi = "10.3389/fimmu.2018.02029",
language = "English",
volume = "9",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Editorial

T2 - Targeting metabolism in cancer immunotherapy

AU - Roszik, Jason

AU - Tanese, Keiji

AU - Ekmekcioglu, Suhendan

PY - 2018/9/11

Y1 - 2018/9/11

KW - Cancer

KW - Immune cells

KW - Immunotherapy

KW - Metabolism

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85053133098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053133098&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2018.02029

DO - 10.3389/fimmu.2018.02029

M3 - Editorial

C2 - 30254633

AN - SCOPUS:85053133098

VL - 9

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - SEP

M1 - 2029

ER -